Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: ARIXTRA Local Study For Registration In China. [Phase 3]
Phase 3 trial update for ARIXTRA evaluating prophylaxis of venous thromboembolism in knee and hip replacement patients; the study in China h…
-
EMA label_change · 2012-05-25European Medicines Agency updates patient and prescriber information for Pradaxa
EMA updates patient and prescriber information for Pradaxa to reflect new safety and usage details.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease
This completed clinical trial evaluated approaches to predict the risk of placental vascular disorders and venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Epidemiology of Thromboembolism Disease: A Cohort Study
A completed cohort study investigating the epidemiology of thromboembolism disease, with results posted in May 2012, sponsored by University…
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency [Phase 4]
Phase 4 trial update shows fondaparinux 1.5 mg was studied for prevention of venous thromboembolism in medical patients with renal insuffici…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
A clinical trial update reporting a systematic review and meta-analysis of venous thromboembolism risk assessment in hospitalized medical pa…
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study [Phase 3]
Phase 3 Einstein-Extension study evaluating once-daily rivaroxaban for long-term prevention of recurrent symptomatic venous thromboembolism …
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery
A terminated clinical trial evaluating Pradaxar (dabigatran) for prevention of venous thromboembolism in Mexican patients undergoing electiv…
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer
This ClinicalTrials.gov update reports on the incidence of venous thromboembolism after surgery in patients with colorectal cancer, with the…
-
FDA approval · 2012-03-27FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Jantoven (warfarin sodium) submitted by Upsher-Smith Laboratories.
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer
This completed clinical trial investigated venous thromboembolism and haemostatic disturbances in patients with upper gastrointestinal cance…
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE [Phase 3]
Phase 3 trial results for dabigatran etexilate in the long-term prevention of recurrent symptomatic venous thromboembolism have been posted.
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement [Phase 3]
A Phase 3 trial comparing switching from enoxaparin to rivaroxaban to prevent postoperative blood clots following total hip or total knee re…
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®
An observational study evaluating the safety and tolerability of prolonged thrombosis prophylaxis with Fragmin (dalteparin) in patients at r…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge
A completed retrospective study sponsored by Brigham and Women's Hospital evaluating risk factors for venous thromboembolism at hospital dis…
-
CLINICAL_TRIALS research · 2012-02-06Clinical Trial Update: Venous Thromboembolism Prophylaxis Post Cesarean Section
This entry notes an ongoing trial at King Saud University evaluating venous thromboembolism prophylaxis after cesarean section; the current …
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization
A completed clinical trial assessed the risk of pulmonary embolism and venous thromboembolism in pregnancies after in vitro fertilization.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Graduated Compression Stockings (GCS) Pilot Substudy [Phase 3]
Phase 3 pilot substudy evaluating graduated compression stockings for venous thromboembolism; the trial is completed.
-
CLINICAL_TRIALS research · 2012-01-12Clinical Trial Update: Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery
A clinical trial update evaluating the safety profile of rivaroxaban for venous thromboembolism prophylaxis after hip fracture surgery. The …
-
CLINICAL_TRIALS research · 2012-01-05Clinical Trial Update: ICU Venous Thromboembolism Incidence Study in a Chinese Population
This document reports an update on an ICU venous thromboembolism incidence study conducted in a Chinese population. The current trial status…
-
FDA approval · 2011-12-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Hospira, Inc.). The update concerns labeling/indications for this a…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement [Phase 2]
A completed Phase 2 trial evaluated a Factor Xa inhibitor for prevention of venous thromboembolism in patients undergoing elective total kne…
-
EMA safety_alert · 2011-11-18European Medicines Agency updates on safety of Pradaxa
EMA updates safety information for Pradaxa (dabigatran) to reflect new risk signals and recommendations for monitoring and use.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer
This completed clinical trial update reports on the incidence of venous thromboembolism following surgery in patients with gastric cancer.
-
FDA approval · 2011-11-09FDA Approved: PRADAXA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals Inc.)
FDA approved Boehringer Ingelheim Pharmaceuticals' supplemental application for Pradaxa (dabigatran etexilate mesylate).